Septerna Inc

SEPN

Healthcare|Biotechnology|USA

$35.93

-1.91 (-5.05%)

Tangible Book

$8.43

Clinical Trials (2)

Trial	Conditions	Phase	Status	Enrollment	Design	Drug
NCT07433179 A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants	Healthy Volunteers	P1	Recruiting	150	RCT, Double-blind	SEP-479
NCT07069036 A Study to Evaluate Single and Multiple Doses of SEP-631 in Healthy Adult Volunteers	Healthy Volunteers	P1	Completed	120	RCT, Double-blind	SEP-631